Abstract:PROteolysis TArgeting Chimeras (PROTACs) have received increasing attention due to their capability to induce potent degradation of various disease-related proteins. However, the effective and controlled cytosolic delivery of current small-molecule PROTACs remains a challenge, primarily due to their intrinsic shortcomings, including unfavorable solubility, poor cell permeability, and limited spatiotemporal precision. Here, we develop a near-infrared (NIR) light-controlled PROTAC delivery device (abbreviated as USDPR) that allows the efficient photoactivation of PROTAC function to achieve enhanced protein degradation. The nanodevice is constructed by encapsulating the commercial BRD4-targeting PROTACs (dBET6) in the hollow cavity of mesoporous silica-coated upconversion nanoparticles (UCNPs), followed by coating a Rose Bengal photosensitizer conjugated poly-L-lysine (PLL-RB). This composition enables NIR light-activatable generation of cytotoxic reactive oxygen species due to the energy transfer from the UCNPs to PLL-RB, which boosts the endo/lysosomal escape and subsequent cytosolic release of dBET6. We demonstrate that USDPR is capable of effectively degrading BRD4 in a NIR light-controlled manner. This in combination with NIR light-triggered photodynamic therapy enables enhanced antitumor effect both in vitro and in vivo. This work thus presents a versatile strategy for controlled release of PROTACs and codelivery with photosensitizers using NIR-responsive nanodevice, providing important insight into the design of effective PROTAC-based combinational therapy.

Azo-PROTAC: Novel Light-Controlled Small-Molecule Tool for Protein Knockdown

PROTACs: an Emerging Targeting Technique for Protein Degradation in Drug Discovery

Light-induced Control of Protein Destruction by Opto-Protac.

Photo-regulated PROTACs: A novel tool for temporal control of targeted protein degradation

Light-Induced Protein Degradation With Photocaged Protacs

Light-Controllable PROTACs for Temporospatial Control of Protein Degradation

Enzyme-catalyzed Activation of Pro-PROTAC for Cell-selective Protein Degradation

PHOTACs enable optical control of protein degradation

Stimuli‐Responsive PROTACs for Controlled Protein Degradation

Proteolysis-targeting chimera (PROTAC) for targeted protein degradation and cancer therapy

Proteolysis Targeting Chimeras for the Selective Degradation of Mcl-1/Bcl-2 Derived from Nonselective Target Binding Ligands

Development of Visible-Light-activatable Photocaged PROTACs

Opportunities and Challenges of Small Molecule Induced Targeted Protein Degradation

Near-Infrared-Activatable PROTAC Nanocages for Controllable Target Protein Degradation and On-Demand Antitumor Therapy.

Precise Modulation of Protein Degradation by Smart PROTACs

Lipid-mediated intracellular delivery of recombinant bioPROTACs for the rapid degradation of undruggable proteins

Smart PROTACs Enable Controllable Protein Degradation for Precision Cancer Therapy

A Photoactivatable Upconverting Nanodevice Boosts the Lysosomal Escape of PROTAC Degraders for Enhanced Combination Therapy

Photopharmacology of Proteolysis-Targeting Chimeras: A New Frontier for Drug Discovery

A Photoactivatable Upconverting Nanodevice Boosts Lysosomal Escape of PROTAC Degraders for Enhanced Combination Therapy

Progress on small-molecule proteolysis-targeting chimeras.